Imc Chicago, LLC Sorrento Therapeutics, Inc. Transaction History
Imc Chicago, LLC
- $4.81 Billion
- Q3 2025
A detailed history of Imc Chicago, LLC transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, Imc Chicago, LLC holds 128,100 shares of SRNE stock, worth $42,273. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128,100Holding current value
$42,273% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SRNE
# of Institutions
13Shares Held
5.37MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA5.22MShares$1.72 Million1.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2110KShares$36,3000.12% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO20.5KShares$6,7650.0% of portfolio
-
Corient Capital Partners, LLC Newport Beach, CA14.9KShares$4,9210.0% of portfolio
-
Huntington National Bank Columbus, OH5KShares$1,6500.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...